Charlie Munger Vice Chairman of world-renowned hedge fund Berkshire Hathaway has based Bitcoin once again.
In an interview he said:
I hate things like Bitcoin, I hate things that are intrinsically antisocial.
This is not the first time he and Warren Buffett of Berkshire Hathaway have bad mouthed the digital currency after they called bitcoin "rat poison" and "rat poison squared,
In the interview he sounded the alarm on the hedge fund industry saying:
People in the investment management industry should prepare for tougher times ahead.
There are wretched excesses in many well paid hedge fund and provate equitiy business.
That sounds like an endorsement for a cryptocurrency if you ask me. They could have many reasons not to like a disruptive technology as they are both old-timers and part of an old system. This is not to say they will not change their minds at some point. There are many old school traders and investors who have jumped on the crypto bandwagon.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.